Quantcast
Last updated on April 20, 2014 at 0:02 EDT

The Center for Animal Health Innovation Makes Award to Kansas State University Researcher

May 14, 2012

Olathe, Kan., May 14, 2012 /PRNewswire/ — A leading researcher at Kansas State University has been awarded $250,000 from the Center for Animal Health Innovation’s (CAHI) Proof-of-Concept (PoC) seed funding program. Tonatiuh Melgarejo, DVM, PhD, an Associate Professor at Kansas State University and the principal investigator, will receive the seed funding to assist in the development of a novel class of natural antibiotics for the treatment of mastitis in dairy cattle. In addition to the financial award, Dr. Melgarejo will receive guidance from CAHI’s animal health industry-led Board of Directors to help bring the technology to market.

Melgarejo stated, “My team is proud to be the recipient of seed funding from CAHI as we further our efforts to develop a treatment for mastitis in dairy cattle.” The product in development is a natural antimicrobial peptide derived from water buffalo with a broad spectrum of antimicrobial activity. Water buffalo are known for their inherent resistance to infectious diseases, and the incidence of mastitis is low in this species, as their typical environment entails a heavy microbial load.

The identification of novel ways to effectively treat mastitis is essential to alleviate the financial burden of this disease in dairy cattle, which accounts for a $2 billion annual loss in the US alone. The dairy industry indicates that there are 9.5 million dairy cattle in the US and that 10% to 35% of cattle are affected by mastitis. The eventual product would not necessitate any milk withholding period post-treatment.

“Sourcing early-stage technologies from academic institutions is an important aspect of pipeline development for animal health companies,” says Jeffrey O. Boily, President and CEO of CAHI, “and we are excited to provide this seed funding to Dr. Melgarejo and his team to assist them in developing this exciting and innovative antibiotic.”

CAHI’s Proof-of-Concept seed funding supports academic researchers, entrepreneurs and small companies developing early-stage animal health technologies with high commercial potential. However, a great idea and funding are often not enough to ensure success. The PoC seed funding offers support that includes animal health industry experts, scientists and entrepreneurs who are working together to help these promising technologies have a meaningful impact in the market. The key goal of the program is to retire the business risk in these early-stage projects, thereby increasing their attractiveness to follow-on investment by established animal health companies and professional investors.

About the Center for Animal Health Innovation

The Center for Animal Health Innovation connects innovative technology to industry by bringing innovations, scientists, entrepreneurs, funding, and business services together to produce breakthrough animal health products and services. CAHI’s Board of Directors includes the senior R&D and C Level Executives from Bayer HealthCare LLC Animal Health Division, Boehringer Ingelheim Vetmedica, Inc., Centaur, Inc., CEVA Biomune Company, Hill’s Pet Nutrition and Merck Animal Health, as well as senior executives from the Kansas Bioscience Authority and the Kansas City Area Life Sciences Institute, Inc. CAHI was established in 2011 and is headquartered in Olathe, KS. To learn more, please visit www.animalhealthinnovation.com.

SOURCE Center for Animal Health Innovation


Source: PR Newswire